Promising complexes of acetazolamide for topical ocular administration

Bibliography

• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13(3/4):144-51
   PubMed Web of Science ®Google Scholar
• Ali M, Byrne ME. Challenges and solutions in topical ocular drug-delivery systems. Expert Rev Clin Pharmacol 2008;1(1):145-61
   PubMedGoogle Scholar
• Chen C, Yang J. MI-QSAR models for prediction of corneal permeability of organic compounds. Acta Pharm Sin 2006;27(2):193-204
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm 2002;248(1-2):1-14
   PubMed Web of Science ®Google Scholar
• Granero GE, Longhi MR, Becker C, Biowaiver monographs for immediate release solid oral dosage forms: acetazolamide. J Pharm Sci 2008;97(9):3691-9
   PubMed Web of Science ®Google Scholar
• Andrea Scozzafava A, Luca Menabuoni L, Mincione F, Supuran CT. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. J Med Chem 2002;45:1466-76
   PubMed Web of Science ®Google Scholar
• Centofanti M, Manni GL, Napoli D, Bucci MG. Comparative effects on intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study. Pharmacol Res 1997;35:481-5
   PubMed Web of Science ®Google Scholar
• Portellos M, Buckley E, Freedman SF. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 1998;2:43-7
   PubMedGoogle Scholar
• Maus TL, Larsson LI, McLaren JW, Brubaker RF. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:45-9
   PubMed Web of Science ®Google Scholar
• Larsson LI, Alm A. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol 1998;116:19-24
   PubMed Web of Science ®Google Scholar
• Al-Barrag A, Al-Shaer M, Al-Matary N, Bamashmous M. Oral versus topical carbonic anhydrase inhibitors in ocular hipertension alter scleral tunnel cataract surgery. Clin Ophthalmol 2009;3:357-62
   PubMedGoogle Scholar
• Sugrue MF. Review the preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther 1996;12:363-76
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Stewart WC, Halper LK, Johnson-Pratt L, Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol. J Ocul Pharmacol Ther 2002;18(3):211-20
   PubMed Web of Science ®Google Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004;39:1033-46
   Web of Science ®Google Scholar
• Stella VJ, He Q. Cyclodextrins. Toxicol Pathol 2008;36:30-42
   PubMed Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007;123:78-99
   PubMed Web of Science ®Google Scholar
• Cal K, Centkowska K. Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm 2008;68:467-78
   PubMed Web of Science ®Google Scholar
• Jansook P, Loftsson T. CDs as solubilizers: effects of excipients and competing drugs. Int J Pharm 2009;379:32-40
   PubMedGoogle Scholar
• Wan J, Yuan S, Mak K, Enhanced washing of HCB contaminated soils by methyl-beta-cyclodextrin combined with ethanol. Chemosphere 2009;75:759-64
   PubMed Web of Science ®Google Scholar
• Barillaro V, Dive G, Bertholet P, Theoretical and experimental investigations of organic acids/cyclodextrin complexes and their consequences upon the formation of miconazole/cyclodextrin/acid ternary inclusion complexes. Int J Pharm 2008;347:62-70
   PubMedGoogle Scholar
• Redenti E, Szente L, Szejtli L. cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci 2001;90:979-86
   PubMed Web of Science ®Google Scholar
• Siefert B, Keipert S. Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions. J Pharm Sci 1997;86:716-20
   PubMed Web of Science ®Google Scholar
• Granero G, Garnero C, Longhi M. The effect of a basic substance and pH on cyclodextrin complexation of sulfisoxazole. Eur J Pharm Sci 2003;20:285-93
   PubMed Web of Science ®Google Scholar
• Granero GE, Maitre MM, Garnero C, Longhi MR. Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex. Eur J Med Chem 2008;43:464-70
   PubMed Web of Science ®Google Scholar
• Palma SD, Tartara LI, Quinteros D, An efficient ternary complex of acetazolamide with HP-beta-CD and TEA for topical ocular administration. J Control Release 2009;138:24-31
   PubMed Web of Science ®Google Scholar
• Gloster J, Perkins ES. Effect of a carbonic anhydrase inhibitor (Diamox) on intra-ocular pressure of rabbits and cats. Br J Ophthalmol 1955;39:647-58
   PubMedGoogle Scholar
• Grant WM, Trotter RR. Diamox (acetazolamide) in treatment of glaucoma. Arch Ophthalmol 1954;51:735-9
   PubMed Web of Science ®Google Scholar
• Friedman Z, Allen RC, Raph SM. Topical acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol 1985;103:963-6
   PubMed Web of Science ®Google Scholar
• Kaur IP, Singh M, Kanwar M. Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm 2000;199:119-27
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Pal D, Mitra AK, Kaur IP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int J Pharm 2007;338:21-6
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSci Tech 2007;8:E1-E11
   PubMed Web of Science ®Google Scholar
• Kurishita A, Katoh T, Ohsawa H, Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients. (5) Skin2TM ZK1100 and Tissue Equivalent Assay. Toxicol In Vitro 1999;13:139-51
   PubMed Web of Science ®Google Scholar
• Davis NM, Wang G, Tucker IG. Evaluation of a hydrocortisone/hydroxypropyl-beta-cyclodextrin solution for ocular drug delivery. Int J Pharm 1997;156:201-9
   Google Scholar
• Bary AR, Tucker IG, Davis NM. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone. Eur J Pharm Biopharm 2000;50:237-44
   PubMed Web of Science ®Google Scholar
• Masuda K, Tohno M, Konishi Y, Ocular penetration of flurbiprofen, an anti-inflammatory drug, in rabbits after topical instillation. Atarashii Ganka 1985;2(3):441-3
   Google Scholar
• Jarho P, Jarvinen K, Urtti A, Stella VJ. Modiefied beta-cyclodextrin (SBE7-beta-CYD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. J Pharm Pharmacol 1996;48:263-9
   PubMed Web of Science ®Google Scholar
• Burgalassi S, Cappello B, Chetoni P, Rufloxacin eyedrops: effect of different formulations on ocular pharmacokinetics in rabbits. Eur J Ophthalmol 2006;16(2):311-7
   PubMed Web of Science ®Google Scholar
• Cappello B, Carmignani C, Iervolino M, Solubilization of tropicamide by hydroxypropyl-b-cyclodextrin and water-soluble polymers: in vitro:in vivo studies. Int J Pharm 2001;213:75-81
   PubMed Web of Science ®Google Scholar
• Raffaini G, Ganazzoli F. Hydration and flexibility of alpha-, beta-, gamma- and delta-cyclodextrin: a molecular dynamics study. Chem Phys 2007;333:128-34
   Web of Science ®Google Scholar
• Lo Meo P, D'Anna F, Riela S, Binding equilibria between b-cyclodextrin and p-nitro-aniline derivatives: the first systematic study in mixed water–methanol solvent systems. Tetrahedron 2009;65:2037-42
   Web of Science ®Google Scholar
• Barillaro V, Dive G, Bertholet P, Theoretical and experimental investigations of organic acids/cyclodextrin complexes and their consequences upon the formation of miconazole/cyclodextrin/acid ternary inclusion complexes. Int J Pharm 2008;347:62-70
   PubMedGoogle Scholar
• Loftsson T, Stefansdottir O, Frioriksdottir H, Guomundsson O. Interactions between preservatives and 2-hydroxypropyl-beta-cyclodextrin. Drug Dev Ind Pharm 1992;18(13):1477-84
   Web of Science ®Google Scholar